Obesity, insulin resistance, and type 2 diabetes in children and adolescents

Pediatric Annals

Volumn 35, Issue 11, 2006, Pages 822-826

  Rappaport, Elizabeth B ^a   Usher, David C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; ETHNIC DIFFERENCE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MEDICAL PRACTICE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ONSET AGE; PATHOPHYSIOLOGY; PREVALENCE; REVIEW;

EID: 33845428441     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20061101-10     Document Type: Review

References (35)

1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-1607.
2. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of Overweight and Obesity in the United States, 1999-2004. JAMA. 2006;295(13):1549-1555.
3. Duncan GE, Li SM, Zhou XH. Prevalence and trends of a metabolic syndrome pheno-type among US Adolescents, 1999-2000. Diabetes Care. 2004;27(10):2438- 2443.
4. Diabetes in Children Adolescents Work Group of the National Diabetes Education Program. An Update on Type 2 Diabetes in Youth From the National Diabetes Education Program. Pediatrics. 2004;114(1):259-263.
5. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat. May 2002(246):1-18.
6. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Am J Clin Nutr. 1998;68(4):899-917.
7. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350(23):2362-2374.
8. Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin North Am. 2004;33(2):283-303.
9. Kahn R, Buse J, Ferrannini E, Stern M. The Metabolic Syndrome: Time for a Critical Appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28(9):2289-2304.
10. Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003;9(3):237-252.
11. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the Metabolic Syndrome in American Adolescents: Findings From the Third National Health and Nutrition Examination Survey. Circulation. 2004;110(16):2494-2497.
12. Smoak CG, Burke GL, Webber LS, Harsha DW, Srinivasan SR, Berenson GS. Relation of obesity to clustering of cardiovascular disease risk factors in children and young adults. The Bogalusa Heart Study. Am J Epidemiol. 1987;125(3):364-372.
13. Bao W, Srinivasan SR, Wattigney WA, Berenson GS. Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood. The Bogalusa Heart Study. Arch Intern Med. 1994;154(16):1842-1847.
14. Chen W, Srinivasan SR, Li S, Xu J, Berenson GS. Metabolic Syndrome Variables at Low Levels in Childhood Are Beneficially Associated With Adulthood Cardiovascular Risk: The Bogalusa Heart Study. Diabetes Care. 2005;28(1):126-131.
15. Li S, Chen W, Srinivasan SR, et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA. 2003;290(17):2271-2276.
16. Raitakari OT, Juonala M, Kanonen M, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA. 2003;290(17):2277-2283.
17. Gungor N, Thompson T, Sutton-Tyrrell K, Janosky J, Arslanian S. Early Signs of Cardiovascular Disease in Youth With Obesity and Type 2 Diabetes. Diabetes Care. 2005;28(5):1219-1221.
18. Daniels SR, Loggie JM, Khoury P, Kimball TR. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation. 1998;97(19):1907-1911.
19. Gidding SS, Nehgme R, Heise C, Muscar C, Linton A, Hassink S. Severe obesity associated with cardiovascular deconditioning, high prevalence of cardiovascular risk factors, diabetes mellitus/hyperinsulinemia, and respiratory compromise. J Pediatr. 2004;144(6):766-769.
20. The STOPP-T2D Prevention Study Group. Presence of Diabetes Risk Factors in a Large U.S. Eighth-Grade Cohort. Diabetes Care. 2006;29(2):212-217.
21. Sinha R, Fisch G, Teague B, et al. Prevalence of Impaired Glucose Tolerance among Children and Adolescents with Marked Obesity. N Engl J Med. 2002;346(11):802-810.
22. Fagot-Campagna A. Emergence of type 2 diabetes mellitus in children: epidemiological evidence. J Pediatr Endocrinol Metab. 2000;13 Suppl 6:1395-1402.
23. Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S. Predictors of Changes in Glucose Tolerance Status in Obese Youth. Diabetes Care. 2005;28(4):902-909.
24. McGill HC, Jr., McMahan CA, Malcom GT, Oalmann MC, Strong JP. Relation of Glycohemoglobin and Adiposity to Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol. 1995;15(4):431-440.
25. Hillier TA, Pedula KL. Complications in Young Adults With Early-Onset Type 2 Diabetes: Losing the relative protection of youth. Diabetes Care. 2003;26(11):2999-3005.
26. Eppens MC, Craig ME, Cusumano J, et al. Prevalence of Diabetes Complications in Adolescents With Type 2 Compared With Type 1 Diabetes. Diabetes Care. 2006;29(6):1300-1306.
27. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Let. 2006;580(12):2917-2921.
28. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. Jun 2004;89(6):2548-2556.
29. Martin LJ, Woo JG, Daniels SR, Goodman E, Dolan LM. The relationships of adiponectin with insulin and lipids are strengthened with increasing adiposity. J Clin Endocrinol Metab. Jul 2005;90(7):4255-4259.
30. Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. 2006;83(2):456S-460.
31. Narayan KMV, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime Risk for Diabetes Mellitus in the United States. JAMA. 2003;290(14):1884-1890.
32. Sherry B, Mei Z, Scanlon KS, Mokdad AH. Grummer-Strawn LM. Trends in State-Specific Prevalence of Overweight and Underweight in 2- Through 4-Year-Old Children From Low-Income Families From 1989 Through 2000. Arch Pediatr Adolesc Med. 2004;158(12):1116-1124.
33. Jolliffe D. Extent of overweight among US children and adolescents from 1971 to 2000. Int J Obes Relat Metab Disord. 2004;28(1):4-9.
34. Gordon-Larsen P, Adair LS, Nelson MC, Popkin BM. Five-year obesity incidence in the transition period between adolescence and adulthood: the National Longitudinal Study of Adolescent Health. Am J Clin Nutr. 2004;80(3):569-575.
35. Sturm R. Increases in clinically severe obesity in the United States, 1986-2000. Arch Intern Med. 2003;163(18):2146-2148.